Impact of C1q deficiency on the severity and outcome of childhood systemic lupus erythematosus

International Journal of Rheumatic Diseases

Volumn 14, Issue 1, 2011, Pages 81-85

  Al Mayouf, Sulaiman M ^a   Abanomi, Hind ^a   Eldali, Abdelmoneim ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

C1q deficiency; Children; Familial lupus; Nail dystrophy; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; CREATININE; DOUBLE STRANDED DNA ANTIBODY; LA ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBONUCLEOPROTEIN; RO ANTIBODY; SM ANTIBODY; UREA;

ALOPECIA; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPLEMENT COMPONENT C1Q DEFICIENCY; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEMOLYTIC ANEMIA; HUMAN; INFLAMMATION; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOPENIA; LYMPHOCYTOPENIA; MALE; NAIL DISEASE; NEPHRITIS; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; SAUDI ARABIA; SCAR FORMATION; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS RASH; THROMBOCYTOPENIA; ULCER; UREA BLOOD LEVEL; URINALYSIS;

AGE OF ONSET; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1Q; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; FAMILY HEALTH; FEMALE; HUMANS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NAIL DISEASES; REFERENCE VALUES; SAUDI ARABIA; SEVERITY OF ILLNESS INDEX;

EID: 79551717950     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01574.x     Document Type: Article

References (21)

1. Karp D (2005) Complement and systemic lupus erythematosus. Curr Opin Rheumatol 17, 538-42.
2. Cook H, Botto M (2006) Mechamisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2, 330-7.
3. Sontheirmer R, Racila E, Racila D (2005) C1q: its function within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol 125, 14-23.
4. Ceribelli A, Andreoli L, Cavazzana I, et al. (2009) Complement cascade in systemic lupus erythematosus: analyses of the three activation pathways. Ann N Y Acad Sci 1173, 427-34.
5. Carneiro-Sampaio M, Liphaus B, Jesus A, Silva C, Oliveira J, Kiss M (2008) Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies. J Clin Immunol 28, S34-41.
6. Pickering M, Walport M (2000) Links between complement abnormalities and systemic lupus erythematosus. Rheumatology 39, 133-41.
7. Vassallo G, Newton W, Chieng E, Haeney M, Shabani A, Arkwright P (2007) Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency. Rheumatology 46, 1612-4.
8. Al-Mayouf SM, Majeed M, Al-Mehaidib A, Alsuhaibani H (2002) Pancreatic pseudocyst in paediatric systemic lupus erythematosus. Clin Rheumatol 21, 264-6.
9. Abnomai H, Al-Ghamdi A, Al-Mayouf SM (2008) Unusual extensive ulcerations in a child with juvenile systemic lupus erythematosus and C1q deficiency. Ann Saudi Med 28, 466-8.
10. Tan E, Cohen A, Fries J, et al. (1982) The 1982 revised criteria for the classification of the systemic lupus erythematosus. Arthritis Rheum 25, 1271-7.
11. Brunner H, Silverman E, To T, Bombardier C, Feldman B (2002) Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46, 436-44.
12. Unsworth D (2008) Complement deficiency and disease. J Clin Pathol 61, 1013-7.
13. Manderson A, Botto M, Walport M (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22, 431-56.
14. Trendelenburg M (2005) Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immunopathol 27, 276-85.
15. Böhm I (2004) Apoptosis: the link between autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus. Scand J Rheumatol 33, 409-16.
16. Böhm I (2005) Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies. J Clin Immunol 25, 99-105.
17. Böhm I (2006) Quantification of absolute peripheral white blood cells and their subsets in patients with lupus erythematosus: comparison with other inflammatory diseases with and without autoimmune background. Biomed Pharmacother 60, 92-5.
18. Kirschfink M, Petry F, Khirwadkar K, Wigand R, Kaltwasser J, Loos M (1993) Complete functional C1q deficiency associated with systemic lupus erythematosus. Clin Exp Immunol 94, 267-72.
19. Berkel A, Petry F, Sanal ö, et al. (1997) Development of systemic lupus erythematosus in a patient with selective complete C1q deficiency. Eur J Pediatr 156, 113-5.
20. Stone N, Williams A, Wilkinson J, Bird G (2000) Systemic lupus erythematosus with C1q deficiency. Br J Dermatol 142, 521-4.
21. Kallel-Sellami M, Baili-Klila L, Zerzeri Y, et al. (2007) Pediatric systemic lupus erythematosus with C1q deficiency. Ann N Y Acad Sci 1108, 193-6.